Can individualized sunitinib dose and schedule changes optimize outcomes for kidney cancer patients?

Por Bjarnason, Georg A.
Publicado no Can Urol Assoc J (2016)

From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma

Por Yousef George M, Bjarnason Georg A, Arsanious Androu
Publicado em 2009-03-01

From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma

Por Arsanious, Androu, Bjarnason, Georg A, Yousef, George M
Publicado em 2009

Circadian Variation in the Expression of Cell-Cycle Proteins in Human Oral Epithelium

Por Bjarnason, Georg A., Jordan, Richard C. K., Sothern, Robert B.
Publicado em 1999

CT texture analysis: a potential tool for prediction of survival in patients with metastatic clear cell carcinoma treated with sunitinib

Por Haider, Masoom A., Vosough, Alireza, Khalvati, Farzad, Kiss, Alexander, Ganeshan, Balaji, Bjarnason, Georg A.
Publicado no Cancer Imaging (2017)

Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis

Por Ebos, John M.L., Lee, Christina R., Cruz-Munoz, William, Bjarnason, Georg A., Christensen, James G., Kerbel, Robert S.
Publicado no Cancer Cell (2009)

Circadian Expression of Clock Genes in Human Oral Mucosa and Skin : Association with Specific Cell-Cycle Phases

Por Bjarnason, Georg A., Jordan, Richard C. K., Wood, Patricia A., Li, Qi, Lincoln, David W., Sothern, Robert B., Hrushesky, William J. M., Ben-David, Yaacov
Publicado em 2001

Progression-Free Survival as a Predictor of Overall Survival in Metastatic Renal Cell Carcinoma Treated With Contemporary Targeted Therapy

Por Heng, Daniel Y. C., Xie, Wanling, Bjarnason, Georg A., Vaishampayan, Ulka, Tan, Min-Han, Knox, Jennifer, Donskov, Frede, Wood, Lori, Kollmannsberger, Christian, Rini, Brian I., Choueiri, Toni K.
Publicado em 2010

Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients

Por Donskov, Frede, Michaelson, M Dror, Puzanov, Igor, Davis, Mellar P, Bjarnason, Georg A, Motzer, Robert J, Goldstein, David, Lin, Xun, Cohen, Darrel P, Wiltshire, Robin, Rini, Brian I
Publicado no Br J Cancer (2015)

miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma

Por Khella, Heba W Z, Butz, Henriett, Ding, Qiang, Rotondo, Fabio, Evans, Kenneth R, Kupchak, Peter, Dharsee, Moyez, Latif, Ashraf, Pasic, Maria D, Lianidou, Evi, Bjarnason, Georg A, Yousef, George M
Publicado no Mol Ther (2015)

Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer

Por Innominato, Pasquale F., Focan, Christian, Gorlia, Thierry, Moreau, Thierry, Garufi, Carlo, Waterhouse, Jim, Giacchetti, Sylvie, Coudert, Bruno, Iacobelli, Stefano, Genet, Dominique, Tampellini, Marco, Chollet, Philippe, Lentz, Marie-Ange, Mormont, Marie-Christine, Lévi, Francis, Bjarnason, Georg A.
Publicado em 2009

Lactate Dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma

Por Girgis, Hala, Masui, Olena, White, Nicole MA, Scorilas, Andreas, Rotondo, Fabio, Seivwright, Annetta, Gabril, Manal, Filter, Emily R, Girgis, Andrew HA, Bjarnason, Georg A, Jewett, Michael AS, Evans, Andrew, Al-Haddad, Sahar, Siu, KW Michael, Yousef, George M
Publicado em 2014

Sunitinib dose-escalation overcomes transient resistance in clear cell renal cell carcinoma and is associated with epigenetic modifications

Por Adelaiye, Remi, Ciamporcero, Eric, Miles, Kiersten Marie, Sotomayor, Paula, Bard, Jonathan, Tsompana, Maria, Conroy, Dylan, Shen, Li, Ramakrishnan, Swathi, Ku, Sheng-Yu, Orillion, Ashley, Prey, Joshua, Fetterly, Gerald, Buck, Michael, Chintala, Sreenivasulu, Bjarnason, Georg A., Pili, Roberto
Publicado no Mol Cancer Ther (2014)

Quantitative Proteomic Analysis in Metastatic Renal Cell Carcinoma Reveals a Unique Set of Proteins with Potential Prognostic Significance

Por Masui, Olena, White, Nicole M. A., DeSouza, Leroi V., Krakovska, Olga, Matta, Ajay, Metias, Shereen, Khalil, Bishoy, Romaschin, Alexander D., Honey, R. John, Stewart, Robert, Pace, Kenneth, Bjarnason, Georg A., Siu, K. W. Michael, Yousef, George M.
Publicado em 2013

Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma

Por White, Nicole M.A., Masui, Olena, DeSouza, Leroi V., Krakovska-Yutz, Olga, Metias, Shereen, Romaschin, Alexander D., Honey, R. John, Stewart, Robert, Pace, Kenneth, Lee, Jason, Jewett, Michael AS, Bjarnason, Georg A., Siu, K.W. Michael, Yousef, George M.
Publicado em 2014

External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study

Por Heng, Daniel Y C, Xie, Wanling, Regan, Meredith M, Harshman, Lauren C, Bjarnason, Georg A, Vaishampayan, Ulka N, Mackenzie, Mary, Wood, Lori, Donskov, Frede, Tan, Min-Han, Rha, Sun-Young, Agarwal, Neeraj, Kollmannsberger, Christian, Rini, Brian I, Choueiri, Toni K
Publicado em 2013

Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study

Por Harshman, Lauren C, Xie, Wanling, Bjarnason, Georg A, Knox, Jennifer J, MacKenzie, Mary, Wood, Lori, Srinivas, Sandy, Vaishampayan, Ulka N, Tan, Min-Han, Rha, Sun-Young, Donskov, Frede, Agarwal, Neeraj, Kollmannsberger, Christian, North, Scott, Rini, Brian I, Heng, Daniel Y C, Choueiri, Toni K
Publicado em 2012

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

Por Motzer, Robert J., Hutson, Thomas E., Tomczak, Piotr, Michaelson, M. Dror, Bukowski, Ronald M., Oudard, Stéphane, Negrier, Sylvie, Szczylik, Cezary, Pili, Roberto, Bjarnason, Georg A., Garcia-del-Muro, Xavier, Sosman, Jeffrey A., Solska, Ewa, Wilding, George, Thompson, John A., Kim, Sindy T., Chen, Isan, Huang, Xin, Figlin, Robert A.
Publicado em 2009

Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy

Por McKay, Rana R., Kroeger, Nils, Xie, Wanling, Lee, Jae-Lyun, Knox, Jennifer J., Bjarnason, Georg A., MacKenzie, Mary J., Wood, Lori, Srinivas, Sandy, Vaishampayan, Ulka N., Rha, Sun-Young, Pal, Sumanta K., Donskov, Frede, Tantravahi, Srinivas K., Rini, Brian I., Heng, Daniel Y. C., Choueiri, Toni K.
Publicado em 2013

Metastatic non clear cell renal cell carcinoma (nccRCC) treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Databas...

Por Kroeger, Nils, Xie, Wanling, Lee, Jae-Lyn, Bjarnason, Georg A., Knox, Jennifer J., MacKenzie, Mary J., Wood, Lori, Srinivas, Sandy, Vaishamayan, Ulka N., Rha, Sun-Young, Pal, Sumanta K., Yuasa, Takeshi, Donskov, Frede, Agarwal, Neeraj, Kollmannsberger, Christian K., Tan, Min-Han, North, Scott A., Rini, Brian I., Choueiri, Toni K., Heng, Daniel Y.C.
Publicado em 2013